Glyxambi

List of products in the National Drug Code with proprietary name glyxambi. This medication is a combination of 2 drugs: empagliflozin and linagliptin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Linagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0597-0164Glyxambi Empagliflozin And LinagliptinTablet, Film CoatedOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug
0597-0182Glyxambi Empagliflozin And LinagliptinTablet, Film CoatedOralBoehringer Ingelheim Pharmaceuticals, Inc.Human Prescription Drug